An interventional study of CDSS simulation and Focus group - clinicians in Adolescent Idiopathic Scoliosis (AIS), sponsored by Istituto Scientifico Italiano Colonna Vertebrale. Active, not recruiting at 1 site in Italy. Open to participants aged 10 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Istituto Scientifico Italiano Colonna Vertebrale · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Scoliosis by Istituto Scientifico Italiano Colonna Vertebrale — 2 open to participants now, 9 under way, none of them phase 3. Scoliosis · Istituto Scientifico Italiano Colonna Vertebrale.
Among the 11 studies in Scoliosis by Istituto Scientifico Italiano Colonna Vertebrale, this one is one of 2 that started in 2025, is the only one with no phase, and was the 10th registered.
660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.
Browse Scoliosis studies →2 of the 11 studies in Scoliosis by Istituto Scientifico Italiano Colonna Vertebrale are open now, in 1 country. Recruiting first, the newest first:
Istituto Scientifico Italiano Colonna Vertebrale · Sites in Italy
Ages 10+
Istituto Scientifico Italiano Colonna Vertebrale · Sites in Italy
Ages up to 16
By country, each count listing its studies:
Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.
This study: 10 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 178 is above the median of 45 across 386 interventional studies indexed under Scoliosis.
Median enrollment 178 across the 1 interventional studies, 545 across the 10 observational. Of the 2 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istituto Scientifico Italiano Colonna Vertebrale is the lead sponsor of 13 studies on the registry; 4 are open to participants now.
1 of the studies in Scoliosis by Istituto Scientifico Italiano Colonna Vertebrale that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07379593Istituto Scientifico Italiano Colonna VertebraleValidation of the Clinical Decision Support Systems (CDSS) Developed in the EU Horizon PREPARE Project in the Rehabilitative Treatment of Idiopathic Scoliosis | 2027-03-01 |
Add it to your calendar (.ics) → With an account.
Among the 11 studies in Scoliosis by Istituto Scientifico Italiano Colonna Vertebrale, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study aims to validate both the predictive capacity and the clinical usability of the Clinical Decision Support System (CDSS) developed within the PREPARE project (European Union Grant Agreement 101080288 PREPARE HORIZON-HLTH-2022-TOOL-12-01) for the management of idiopathic scoliosis (IS). This will be achieved through simulation-based studies.
Study Population:
Three participant groups will be included:
All participants must have adequate cognitive and language abilities to take part in discussions and complete questionnaires.
Sample Size:
Part I: Involves the 8 ISICO physicians performing clinical visits.
The main outcome measure is the variation in treatment decisions before and after exposure to the CDSS.
With α = 0.05, power = 80%, and expected effect size (Cohen's d = 0.3), the minimum required sample size is 175 clinical cases.
Parts II-III (Focus Groups):
6-12 patients
6-12 parents
6-10 physicians These group sizes align with qualitative research standards to ensure thematic saturation.
Safety Evaluation:
Adverse events will be monitored, recorded, and assessed by the Data Safety Monitoring Committee (DSMC).
Statistical and Analytical Plan:
Quantitative analysis will evaluate:
The frequency, nature, and motivations behind changes in treatment plans after using CDSS recommendations.
Correlations between CDSS suggestions and clinicians' treatment decisions.
Qualitative analysis will interpret data from focus group discussions to identify patterns, trends, and associations between CDSS recommendations, clinical choices, and possible alternative decisions had the CDSS been applied.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The study aims to investigate the potential clinical impact of the CDSS on the prescription of rehabilitative treatment for idiopathic scoliosis (IS). Specifically, it seeks to answer the following question: Would clinical decisions regarding the treatment of IS have changed if clinicians had access to the information provided by the CDSS to discuss with the patient?
Other: CDSS simulation
Focus grous designed to explore the perspectives, experiences, and perceptions of physicians regarding the use of the CDSS in daily clinical practice.
Other: Focus group - clinicians
The main objective is to explore patients' perspectives on the implementation of CDSS. The aim is to understand patients' experiences with CDSS, including their interactions with the system and their perceptions of its usefulness and relevance in the care pathway. The study also seeks to identify factors that influence patients' acceptance and usability of CDSS, such as interface design, clarity of information, and alignment with patients' preferences. Finally, we aim to evaluate the impact of CDSS on patient engagement and their satisfaction with the care experience, including the extent to which CDSS facilitate informed decision-making and communication between patients and healthcare providers.
Other: Focus group - patients
The intervention planned in this study consists of a simulation, carried out by physicians, of the use of a Clinical Decision Support System (CDSS) designed to support informed decision-making in prescribing rehabilitative treatment for idiopathic scoliosis (IS). Physicians will continue their routine clinical practice and will subsequently be exposed to the CDSS results for the same cases they had previously assessed, after a three-month interval (the typical period between a visit and a follow-up). This delay is intended to minimize recall bias and to ensure that exposure to the CDSS does not retrospectively influence their therapeutic decisions, thereby avoiding any interference with their daily clinical activity. The study will simulate the integration of the CDSS into the clinicians' routine workflow. The CDSS will be developed based on advanced computational models using artificial intelligence, specifically adapted to the rehabilitation context for IS, and created during the f
Focus group aimed at exploring how the implementation of the CDSS has influenced the clinical practice of physicians who previously simulated its integration into their professional activity, as well as their decision-making processes and approaches to patient care.
Two separate focus groups will be organized: one for patients and one for parents. During the sessions, hypothetical clinical scenarios involving the use of CDSS in their care pathway will be presented. The scenarios will be identical for both groups. Participants will be encouraged to share their opinions, thoughts, and feelings regarding CDSS. Facilitators will guide the discussion, ensuring that all participants have the opportunity to express their views and that diverse perspectives are collected.
Changes in clinical decision
To assess the impact of the CDSS on clinical decisions, a mixed-methods approach, combining quantitative and qualitative analyses, will be adopted. The primary quantitative outcome measure will be the proportion of clinical cases in which the therapeutic decision changes after exposure to the CDSS, defined as a binary outcome (change vs. no change in treatment plan). Therapeutic decisions made before and after CDSS consultation will be compared within the same case. Differences in paired pre- and post-CDSS therapeutic decisions will be evaluated using McNemar's test, which is appropriate for assessing changes in paired binary outcomes. Qualitative analyses will explore clinicians' rationale for decision changes and their perceptions of CDSS influence.
Time frame: Throughout study completion, an avarage of 6 months
Plan to share: Yes — Aninymized data will be uploaded on a public repository
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Mar 2027, 15 months after the start.
Of 224 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 15 months is below that.
Counting every sponsor, half of 234 studies reached it within 22 months; a quarter within 8 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istituto Scientifico Italiano Colonna Vertebrale